Document is current
Any future updates will be listed below
-
Authors
Cowan, Quinn T. https://orcid.org/0000-0002-8697-8178
Gu, Sifeng
Gu, Wanjun
Ranzau, Brodie L. https://orcid.org/0000-0002-6170-7187
Simonson, Tatum S. https://orcid.org/0000-0003-4062-2587
Komor, Alexis C. https://orcid.org/0000-0001-5043-0998
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R35GM138317)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM008326)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM112584)
Research Corporation for Science Advancement (28385)
- License Information
-
More Information
Article History
Received: 6 May 2022
Accepted: 10 April 2024
First Online: 21 May 2024
Competing interests
: A.C.K. is a member of the SAB of Pairwise Plants, is an equity holder for Pairwise Plants and Beam Therapeutics, and receives royalties from Pairwise Plants, Beam Therapeutics and Editas Medicine via patents licensed from Harvard University. A.C.K.’s interests have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies. A.C.K. and Q.T.C. are listed as inventors in a Regents of the University of California patent application (PCT/US23/66812) on the development and application of multiplexed orthogonal base editing systems in living cells. All other authors declare no competing financial interests.
